Atherosclerotic Plaque Epigenetic Age Acceleration Predicts a Poor Prognosis and Is Associated With Endothelial-to-Mesenchymal Transition in Humans

/
/
Atherosclerotic Plaque Epigenetic Age Acceleration Predicts a Poor Prognosis and Is Associated With Endothelial-to-Mesenchymal Transition in Humans

Atherosclerotic Plaque Epigenetic Age Acceleration Predicts a Poor Prognosis and Is Associated With Endothelial-to-Mesenchymal Transition in Humans (https://doi.org/10.1161/ATVBAHA.123.320692)

Zoom link for the 14th of October webinar 3pm CET: https://ki-se.zoom.us/j/65517879287 

Dr. Diez Benavente is an Assistant Professor in Experimental Cardiology at the UMC Utrecht (Netherlands). His research focuses on the analysis of complex biological data to understand sex differences and mechanisms of ageing in atherosclerosis. In addition, he is strongly motivation to valorize his scientific findings into clinically relevant technologies and assays to improve the management and diagnosis of cardiovascular diseases in women and men.

Facebook
Twitter
LinkedIn
WhatsApp
Email

Latest Updates

Abstract Atherosclerotic cardiovascular disease (ASCVD) is among the leading causes of death worldwide, and technological...
The Impact of Academic Research on Pharmaceutical Success Insights from Developing Cardiovascular Medicines May 2025...
High throughput methods for evaluation of changes in composition webinar on February 26, 2025
The basics of RNA sequencing webinar on December 4, 2024
Dr. Ernest Diez Benavente from UMC Utretcht
Dr. Bram Slütter from Leiden University – Resident Memory T Cells in the Atherosclerotic Lesion...

Learn how we helped 100 top brands gain success